MYOLARIS Trademark

Trademark Overview

On Thursday, May 12, 2022, a trademark application was filed for MYOLARIS with the United States Patent and Trademark Office. The USPTO has given the MYOLARIS trademark a serial number of 97408309. The federal status of this trademark filing is REGISTERED as of Tuesday, May 26, 2026. This trademark is owned by Olaris, Inc.. The MYOLARIS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Medical diagnostic solutions and platforms for medical and research purposes, namely, medical apparatus for testing the presence of biomarkers relevant for treatment responsiveness and drug efficacy

Providing medical and scientific testing information services for medical and scientific research purposes, namely, reporting test results and analysis of customers tests; computer aided biomarker discovery services for identifying potential biomarkers for use in researching disease, diagnosis of disease, drug compound safety, drug efficacy, treatment efficacy, therapy responsiveness, and drug side-effects; providing scientific analysis and informational reports based upon results of laboratory testing in the field of diagnostics and biomarkers; providing online computer databases featuring scientific information based on aggregated results of biomarker testing

General Information

Serial Number97408309
Word MarkMYOLARIS
Filing DateThursday, May 12, 2022
Status700 - REGISTERED
Status DateTuesday, May 26, 2026
Registration Number8274306
Registration DateTuesday, May 26, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2023

Trademark Statements

Goods and ServicesMedical diagnostic solutions and platforms for medical and research purposes, namely, medical apparatus for testing the presence of biomarkers relevant for treatment responsiveness and drug efficacy
Pseudo MarkMY OLARIS
Goods and ServicesProviding medical and scientific testing information services for medical and scientific research purposes, namely, reporting test results and analysis of customers tests; computer aided biomarker discovery services for identifying potential biomarkers for use in researching disease, diagnosis of disease, drug compound safety, drug efficacy, treatment efficacy, therapy responsiveness, and drug side-effects; providing scientific analysis and informational reports based upon results of laboratory testing in the field of diagnostics and biomarkers; providing online computer databases featuring scientific information based on aggregated results of biomarker testing

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code010
First Use Anywhere DateMonday, September 30, 2024
First Use In Commerce DateThursday, July 31, 2025
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 20, 2023
Primary Code042
First Use Anywhere DateTuesday, November 5, 2024
First Use In Commerce DateThursday, July 31, 2025

Trademark Owner History

Party NameOlaris, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01702
US
Party NameOlaris, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFramingham, MA 01702
US
Party NameOlaris, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01702
US

Trademark Events

Event DateEvent Description
Monday, May 16, 2022NEW APPLICATION ENTERED
Tuesday, May 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Thursday, March 2, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 2, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 2, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 2, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, March 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 14, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, March 16, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 21, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 21, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, March 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 21, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, March 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 8, 2023SOU EXTENSION 1 FILED
Wednesday, November 8, 2023SOU EXTENSION 1 GRANTED
Friday, November 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 22, 2024SOU EXTENSION 2 FILED
Wednesday, May 22, 2024SOU EXTENSION 2 GRANTED
Thursday, May 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 13, 2024SOU EXTENSION 3 FILED
Saturday, December 14, 2024SOU EXTENSION 3 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 16, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 16, 2025SOU EXTENSION 4 FILED
Friday, May 16, 2025SOU EXTENSION 4 GRANTED
Saturday, May 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 8, 2025SOU TEAS EXTENSION RECEIVED
Monday, December 8, 2025TEAS STATEMENT OF USE RECEIVED
Friday, May 1, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 8, 2025SOU EXTENSION 5 FILED
Friday, May 1, 2026SOU EXTENSION 5 GRANTED
Monday, December 8, 2025USE AMENDMENT FILED
Friday, May 1, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, May 1, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 4, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 4, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 26, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, May 26, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 26, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 26, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

myolaris medical drug testing scientific efficacy biomarkers providing results information research